Literature DB >> 2969991

Hemodialysis-associated subclavian vein stenosis.

S J Schwab1, L D Quarles, J P Middleton, R H Cohan, M Saeed, V W Dennis.   

Abstract

This study was undertaken to evaluate hemodialysis-associated subclavian vein stenosis (SVS) and to clarify treatment of this condition. Forty-seven patients underwent upper arm venography to evaluate fistula dysfunction. Subclavian vein stenosis was documented in 12. Eleven of 12 had elevated venous dialysis pressure (196 +/- 8.9 mm Hg), and six had arm edema. All 12 had previously undergone subclavian cannulation on the side of the fistula. Thirty-five patients showed no evidence of subclavian vein stenosis. Twelve of these 35 patients (mean venous dialysis pressure 113 +/- 2.3 mm Hg) had undergone previous subclavian cannulation on the side of the fistula. The mean age of the fistula at the time of venogram in patients with subclavian vein stenosis was 17.0 months versus 5.8 months in patients with ipsilateral subclavian cannulation without subclavian vein stenosis. Percutaneous transluminal angioplasty (PTA) was performed on 11 of 12 patients with SVS lowering venous dialysis pressure and restoring patency to the fistula in 100%. Lesions recurred in two of 11 patients and were successfully retreated with PTA. We conclude that SVS is a common dialysis problem that is amenable to treatment with PTA. Elevated venous dialysis pressures are a sensitive indicator of this condition.

Entities:  

Mesh:

Year:  1988        PMID: 2969991     DOI: 10.1038/ki.1988.124

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Fibrin sheath angioplasty: a technique to prevent superior vena cava stenosis secondary to dialysis catheters.

Authors:  Robert I Hacker; Lorena De Marco Garcia; Ankur Chawla; Thomas F Panetta
Journal:  Int J Angiol       Date:  2012-09

2.  Demands for vascular access in a renal dialysis unit: implications for a regional vascular unit.

Authors:  E Eguare; S Tierney; R Maher; M Creamer; P Grace; C J Cronin; P Burke
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

3.  Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department.

Authors:  Daniel Theodoro; Missy Krauss; Marin Kollef; Bradley Evanoff
Journal:  Acad Emerg Med       Date:  2010-10       Impact factor: 3.451

4.  K/DOQI Guidelines: What Should an Interventionalist Know?

Authors:  Aalpen A Patel; Catherine M Tuite; Scott O Trerotola
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

5.  Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Authors:  Douglas M Silverstein; Scott O Trerotola; Timothy Clark; Garth James; Wing Ng; Amy Dwyer; Marius C Florescu; Roman Shingarev; Stephen R Ash
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-11       Impact factor: 8.237

Review 6.  Continuous Renal Replacement Therapy: Who, When, Why, and How.

Authors:  Srijan Tandukar; Paul M Palevsky
Journal:  Chest       Date:  2018-09-25       Impact factor: 9.410

7.  Radiologists need to be aware of secondary central venous stenosis in patients with SAPHO syndrome.

Authors:  Mizuho Suzuki; Hidenori Kanazawa; Takeshi Shinozaki; Hideharu Sugimoto
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

8.  Femoral arteriovenous fistula: a complication of temporary hemodialysis catheter placement.

Authors:  Gen Kuramochi; Nobumasa Ohara; Shin Hasegawa; Hisanaga Moro
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

Review 9.  Vascular access for hemodialysis: A perpetual challenge.

Authors:  Mariana Murea; Randolph L Geary; Ross P Davis; Shahriar Moossavi
Journal:  Semin Dial       Date:  2019-06-17       Impact factor: 3.455

10.  Misplacement of an internal jugular hemodialysis catheter due to stenosis caused by previous short-term catheterization.

Authors:  Prakash K Dubey
Journal:  Indian J Crit Care Med       Date:  2009 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.